Diagnosis and management of rheumatoid arthritis

American Family Physician

Volumn 84, Issue 11, 2011, Pages 1245-1252

  Wasserman, Amy M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; AUROTHIOMALATE; C REACTIVE PROTEIN; CERTOLIZUMAB PEGOL; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GAMMA LINOLENIC ACID; GOLIMUMAB; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MINOCYCLINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PLACEBO; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RHEUMATOID FACTOR; RITUXIMAB; SALAZOSULFAPYRIDINE; TOCILIZUMAB; TUMOR NECROSIS FACTOR INHIBITOR;

ACUPUNCTURE; ANEMIA; ARTHRALGIA; ARTICLE; BLOOD DISEASE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; DIFFERENTIAL DIAGNOSIS; DRUG MECHANISM; EARLY DIAGNOSIS; EARLY INTERVENTION; ERYTHROCYTE SEDIMENTATION RATE; EYE TOXICITY; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HEMORRHAGIC CYSTITIS; HIRSUTISM; HUMAN; HYPERTENSION; HYPERTHERMIC THERAPY; INFERTILITY; INJECTION SITE PAIN; INJECTION SITE REACTION; JOINT PROSTHESIS; JOINT SWELLING; KIDNEY DISEASE; KINESIOTHERAPY; LIVER DISEASE; LUPUS LIKE SYNDROME; MEDITERRANEAN DIET; MOUTH ULCER; NEOPLASM; OPPORTUNISTIC INFECTION; PATHOPHYSIOLOGY; PATIENT MONITORING; PHYSIOTHERAPY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTEIN BLOOD LEVEL; RADIOGRAPHY; RHEUMATOID ARTHRITIS; RISK FACTOR; SKIN DISEASE; TAI CHI; TERATOGENESIS; TREATMENT DURATION; TUBERCULOSIS; ULTRASOUND THERAPY; VEGETARIAN DIET; YOGA;

EID: 83055199967     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Etiology and pathogenesis of rheumatoid arthritis. In: Firestein GS, Kelley WN, eds. Kelley's Textbook of Rheumatology. 8th ed. Philadelphia, Pa.: Saunders/Elsevier; 2009: 1035-1086.
2. Bathon J, Tehlirian C. Rheumatoid arthritis clinical and laboratory manifestations. In: Klippel JH, Stone JH, Crofford LJ, et al., eds. Primer on the Rheumatic Diseases. 13th ed. New York, NY: Springer; 2008: 114-121.
3. Allaire S, Wolfe F, Niu J, et al. Current risk factors for work disability associated with rheumatoid arthritis. Arthritis Rheum. 2009; 61(3): 321-328.
4. MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000; 43(1): 30-37.
5. Orozco G, Barton A. Update on the genetic risk factors for rheumatoid arthritis. Expert Rev Clin Immunol. 2010; 6(1): 61-75.
6. Balsa A, Cabezón A, Orozco G, et al. Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor. Arthritis Res Ther. 2010; 12(2): R62.
7. McClure A, Lunt M, Eyre S, et al. Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk loci. Rheumatology (Oxford). 2009; 48(11): 1369-1374.
8. Bang SY, Lee KH, Cho SK, et al. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Arthritis Rheum. 2010; 62(2): 369-377.
9. Wilder RL, Crofford LJ. Do infectious agents cause rheumatoid arthritis? Clin Orthop Relat Res. 1991; (265): 36-41.
10. Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010; 376(9746): 1094-1108.
11. Costenbader KH, Feskanich D, Mandl LA, et al. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med. 2006; 119(6): 503. e1-e9.
12. Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. JAMA. 2005; 294(21): 2751-2757.
13. Guthrie KA, Dugowson CE, Voigt LF, et al. Does pregnancy provide vaccine-like protection against rheumatoid arthritis? Arthritis Rheum. 2010; 62(7): 1842-1848.
14. Karlson EW, Mandl LA, Hankinson SE, et al. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum. 2004; 50(11): 3458-3467.
15. Karlson EW, Shadick NA, Cook NR, et al. Vitamin E in the primary prevention of rheumatoid arthritis: the Women's Health Study. Arthritis Rheum. 2008; 59(11): 1589-1595.
16. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative [published correction appears in Ann Rheum Dis. 2010; 69(10): 1892]. Ann Rheum Dis. 2010; 69(9): 1580-1588.
17. van der Helm-van Mil AH, le Cessie S, van Dongen H, et al. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis. Arthritis Rheum. 2007; 56(2): 433-440.
18. Mochan E, Ebell MH. Predicting rheumatoid arthritis risk in adults with undifferentiated arthritis. Am Fam Physician. 2008;77(10):1451-1453.
19. Ravelli A, Felici E, Magni-Manzoni S, et al. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. Arthritis Rheum. 2005; 52(3): 826-832.
20. Wilson A, Yu HT, Goodnough LT, et al. Prevalence and outcomes of anemia in rheumatoid arthritis. Am J Med. 2004; 116(suppl 7A): 50S-57S.
21. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008; 59(6): 762-784.
22. Deighton C, O'Mahony R, Tosh J, et al.; Guideline Development Group. Management of rheumatoid arthritis: summary of NICE guidance. BMJ. 2009; 338: b702.
23. AHRQ. Choosing medications for rheumatoid arthritis. April 9, 2008. http://www.effectivehealthcare.ahrq.gov/ehc/products/14/85/RheumArthritisClinicianGuide.pdf. Accessed June 23, 2011.
24. Choy EH, Smith C, Doré CJ, et al. A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal. Rheumatology (Oxford). 2005; 44(11): 1414-1421.
25. Smedslund G, Byfuglien MG, Olsen SU, et al. Effectiveness and safety of dietary interventions for rheumatoid arthritis. J Am Diet Assoc. 2010; 110(5): 727-735.
26. Hagen KB, Byfuglien MG, Falzon L, et al. Dietary interventions for rheumatoid arthritis. Cochrane Database Syst Rev. 2009; 21(1): CD006400.
27. Wang C, de Pablo P, Chen X, et al. Acupuncture for pain relief in patients with rheumatoid arthritis: a systematic review. Arthritis Rheum. 2008; 59(9): 1249-1256.
28. Kelly RB. Acupuncture for pain. Am Fam Physician. 2009; 80(5): 481-484.
29. Robinson V, Brosseau L, Casimiro L, et al. Thermotherapy for treating rheumatoid arthritis. Cochrane Database Syst Rev. 2002; 2(2): CD002826.
30. Casimiro L, Brosseau L, Robinson V, et al. Therapeutic ultrasound for the treatment of rheumatoid arthritis. Cochrane Database Syst Rev. 2002; 3(3): CD003787.
31. Cameron M, Gagnier JJ, Chrubasik S. Herbal therapy for treating rheumatoid arthritis. Cochrane Database Syst Rev. 2011; (2): CD002948.
32. Brodin N, Eurenius E, Jensen I, et al. Coaching patients with early rheumatoid arthritis to healthy physical activity. Arthritis Rheum. 2008; 59(3): 325-331.
33. Baillet A, Payraud E, Niderprim VA, et al. A dynamic exercise programme to improve patients' disability in rheumatoid arthritis: a prospective randomized controlled trial. Rheumatology (Oxford). 2009; 48(4): 410-415.
34. Hurkmans E, van der Giesen FJ, Vliet Vlieland TP, et al. Dynamic Exercise programs (aerobic capacity and/or muscle strength training) in patients with rheumatoid arthritis. Cochrane Database Syst Rev. 2009; (4): CD006853.
35. Han A, Robinson V, Judd M, et al. Tai chi for treating rheumatoid arthritis. Cochrane Database Syst Rev. 2004; (3): CD004849.
36. Evans S, Cousins L, Tsao JC, et al. A randomized controlled trial examining Iyengar yoga for young adults with rheumatoid arthritis. Trials. 2011; 12: 19.
37. Katchamart W, Johnson S, Lin HJ, et al. Predictors for remission in rheumatoid arthritis patients: a systematic review. Arthritis Care Res (Hoboken). 2010; 62(8): 1128-1143.
38. Wolfe F, Zwillich SH. The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum. 1998; 41(6): 1072-1082.
39. Baecklund E, Iliadou A, Askling J, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006; 54(3): 692-701.
40. Friedewald VE, Ganz P, Kremer JM, et al. AJC editor's consensus: rheumatoid arthritis and atherosclerotic cardiovascular disease. Am J Cardiol. 2010; 106(3): 442-447.
41. Atzeni F, Turiel M, Caporali R, et al. The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases. Autoimmun Rev. 2010; 9(12): 835-839.